TP53 and head and neck squamous cell carcinoma: (16) analyzed Tumor Protein 53 (TP53) gene mutations in the DNA of 560 HNSCC patients using gene microarray and high-performance liquid chromatography and found that TP53 mutations were present in 53.3% of HNSCC patients.